Status:
COMPLETED
Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation
Lead Sponsor:
Amgen
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to collect local laboratory data on immunoreactive parathyroid hormone (iPTH), calcium and phosphorus levels and estimated glomerular filtration rate (GFR) at approximatel...
Eligibility Criteria
Inclusion
- \- Patients who withdrew from one of the qualifying studies (i.e. patient previously took part in an Amgen study investigating the drug AMG 073 and its effects on secondary hyperparathyroidism \[HPT\]; in particular parathyroid hormone \[PTH\], calcium and phosphorus levels in blood associated with kidney failure) due to kidney transplantation.
Exclusion
- \- Patient has any kind of disorder that compromises the ability of the subject to give written informed consent
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2004
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00110656
Start Date
March 1 2004
End Date
October 1 2004
Last Update
January 21 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.